Gene · 4773
Papers3,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A longer isoform of Stim1 is a negative SOCE regulator but increases cAMP-modulated NFAT signaling. | EMBO Rep | 2022 | 34942054 | PubTator, text mining | PubMed |
| Correction: Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signaling. | Br J Cancer | 2022 | 34937948 | PubTator, text mining | PubMed |
| NFAT inhibitor 11R-VIVIT ameliorates mouse renal fibrosis after ischemia-reperfusion-induced acute kidney injury. | Acta Pharmacol Sin | 2022 | 34937917 | PubTator, text mining | PubMed |
| Cyclosporine Induces Fenestra-Associated Injury in Human Renal Microvessels In Vitro. | ACS Biomater Sci Eng | 2022 | 34927415 | PubTator, text mining | PubMed |
| The ion channel TRPV1 gain-of-function reprograms the immune microenvironment to facilitate colorectal tumorigenesis. | Cancer Lett | 2022 | 34920021 | PubTator, text mining | PubMed |
| Epigenetic regulation of natural killer cell memory. | Immunol Rev | 2022 | 34908173 | PubTator, text mining | PubMed |
| Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma. | Cancer Res | 2022 | 34903601 | PubTator, text mining | PubMed |
| A polypeptide inhibitor of calcineurin blocks the calcineurin-NFAT signalling pathway in vivo and in vitro. | J Enzyme Inhib Med Chem | 2022 | 34894973 | PubTator, text mining | PubMed |
| NFAT-dependent and -independent exhaustion circuits program maternal CD8 T cell hypofunction in pregnancy. | J Exp Med | 2022 | 34882194 | PubTator, text mining | PubMed |
| The molecular mechanism of chronic stress affecting the occurrence and development of breast cancer and potential drug therapy. | Transl Oncol | 2022 | 34875482 | PubTator, text mining | PubMed |
| High-throughput ex vivo drug testing identifies potential drugs and drug combinations for NRAS-positive malignant melanoma. | Transl Oncol | 2022 | 34837846 | PubTator, text mining | PubMed |
| Single-Cell Transcriptome Profiling Reveals Multicellular Ecosystem of Nucleus Pulposus during Degeneration Progression. | Adv Sci (Weinh) | 2022 | 34825784 | PubTator, text mining | PubMed |
| TCR-independent Activation in Presence of a Src-family Kinase Inhibitor Improves CAR-T Cell Product Attributes. | J Immunother | 2022 | 34802014 | PubTator, text mining | PubMed |
| Membrane-Initiated Estrogen, Androgen, and Progesterone Receptor Signaling in Health and Disease. | Endocr Rev | 2022 | 34791092 | PubTator, text mining | PubMed |
| Dose- and sex-dependent effects of phlebotomy-induced anemia on the neonatal mouse hippocampal transcriptome. | Pediatr Res | 2022 | 34775474 | PubTator, text mining | PubMed |
| Genome-wide association study identifies quantitative trait loci affecting cattle temperament. | Zool Res | 2022 | 34766477 | PubTator, text mining | PubMed |
| Diagnosis of soft tissue tumors using immunohistochemistry as a surrogate for recurrent fusion oncoproteins. | Semin Diagn Pathol | 2022 | 34750023 | PubTator, text mining | PubMed |
| Revelation of Pivotal Genes Pertinent to Alzheimer's Pathogenesis: A Methodical Evaluation of 32 GEO Datasets. | J Mol Neurosci | 2022 | 34668150 | PubTator, text mining | PubMed |
| Genetic inhibition of nuclear factor of activated T-cell c2 prevents atrial fibrillation in CREM transgenic mice. | Cardiovasc Res | 2022 | 34648001 | PubTator, text mining | PubMed |
| Immunogenomic characterization in gastric cancer identifies microenvironmental and immunotherapeutically relevant gene signatures. | Immun Inflamm Dis | 2022 | 34582114 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4773/papers?page=39